The human IGF2 gene, which encodes a mitogenic peptide required for normal fetal development, is overexpressed in many types of tumors. IGF2 is transcribed from four promoters (P1-P4), and in most tissues, the gene is imprinted. In this study, we have analyzed IGF2 promoter usage and determined the allelic expression from each promoter in 19 ApaI- and 22 AluI-heterozygous Wilms' tumors. Loss of IGF2 imprinting (LOI) was observed in 8 ApaI-informative tumors. In these tumors, each parental allele was expressed in equal abundance, indicating that there was complete relaxation of IGF2 imprinting. In each LOI tumor, expression from promoter P1 as well as from the normally imprinted promoters P2-P4 was biallelic. In the 11 ApaI-informative tumors which maintained IGF2 imprinting (maintenance of imprinting), transcription from promoters P2-P4 was always monoallelic, while transcripts from P1 were derived from either one or both alleles. The lack of consistency of IGF2 imprinting of promoter P1 in maintenance of imprinting tumors was also observed in normal fetal tissues of 6-12 weeks gestation, suggesting a similarity in IGF2 regulation between Wilms' tumors and embryonic tissue development. These data suggest that the increased expression of IGF2 in Wilms' tumor may be caused either by biallelic gene expression in LOI tumors from promoters P2-P4 and/or by a reversion to an earlier stage of development which is characterized by increased synthesis of this fetal growth factor.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. Hsu and C. A. Feghali-Bostwick Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways Am. J. Pathol., June 1, 2008; 172(6): 1580 - 1590. [Abstract] [Full Text] [PDF]

				H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer Cancer Res., November 15, 2007; 67(22): 10753 - 10758. [Abstract] [Full Text] [PDF]

				Y. Yang, T. Li, T. H. Vu, G. A. Ulaner, J.-F. Hu, and A. R. Hoffman The Histone Code Regulating Expression of the Imprinted Mouse Igf2r Gene Endocrinology, December 1, 2003; 144(12): 5658 - 5670. [Abstract] [Full Text] [PDF]

				G. A. Ulaner, Y. Yang, J.-F. Hu, T. Li, T. H. Vu, and A. R. Hoffman CTCF Binding at the Insulin-Like Growth Factor-II (IGF2)/H19 Imprinting Control Region Is Insufficient to Regulate IGF2/H19 Expression in Human Tissues Endocrinology, October 1, 2003; 144(10): 4420 - 4426. [Abstract] [Full Text] [PDF]

				T. H. Vu, N. V. Chuyen, T. Li, and A. R. Hoffman Loss of Imprinting of IGF2 Sense and Antisense Transcripts in Wilms' Tumor Cancer Res., April 15, 2003; 63(8): 1900 - 1905. [Abstract] [Full Text] [PDF]

				G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549. [Abstract] [Full Text] [PDF]

				T. Li, T. H. Vu, K.-O. Lee, Y. Yang, C. V. Nguyen, H. Q. Bui, Z.-L. Zeng, B. T. Nguyen, J.-F. Hu, S. K. Murphy, et al. An Imprinted PEG1/MEST Antisense Expressed Predominantly in Human Testis and in Mature Spermatozoa J. Biol. Chem., April 12, 2002; 277(16): 13518 - 13527. [Abstract] [Full Text] [PDF]

				D. Prawitt, T. Enklaar, G. Klemm, B. Gartner, C. Spangenberg, A. Winterpacht, M. Higgins, J. Pelletier, and B. Zabel Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression Hum. Mol. Genet., January 22, 2000; 9(2): 203 - 216. [Abstract] [Full Text] [PDF]

				J.-F. Hu, T. H. Vu, and A. R. Hoffman Genomic Deletion of an Imprint Maintenance Element Abolishes Imprinting of Both Insulin-like Growth Factor II and H19 J. Biol. Chem., August 15, 1997; 272(33): 20715 - 20720. [Abstract] [Full Text] [PDF]

				W.-H. Wang, J.-X. Duan, T. H. Vu, and A. R. Hoffman Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity J. Biol. Chem., November 1, 1996; 271(44): 27863 - 27870. [Abstract] [Full Text] [PDF]

				J.-F. Hu, T. H. Vu, and A. R. Hoffman Promoter-specific Modulation of Insulin-like Growth Factor II Genomic Imprinting by Inhibitors of DNA Methylation J. Biol. Chem., July 26, 1996; 271(30): 18253 - 18262. [Abstract] [Full Text] [PDF]